PDP
PDP
Skip to content Skip to navigation menu
Your browser is not supported by this site.
Please update to the latest version, or use a different browser for the best experience.
ProView Plus Print Toxic Torts Practice Guide

Product details:

Format: Book and Electronic
Brand: Clark Boardman Callaghan
Copyright: 2021
Service #: 30921706
Sub #: 30925470
Publication Frequency: Updated as changes in the law dictate
Update format: N/A

Can we help?

Contact Us 
Call 1-888-728-7677

ProView Plus Print Toxic Torts Practice Guide

106699373

Availability:

In stock
(details)

106699373
106699373
Book and Electronic
Special pricing applies

This updated second edition of the original authority on toxic torts, Toxic Torts Practice Guide, builds on the strengths of the first. It covers the scientific underpinnings of toxic torts, how to structure a case from either the plaintiff's or defendant's perspective, as well as issues in establishing proof of exposure, injury, and causation.

You'll find traditional toxic tort topics, such as theories of liability, discovery, damages, class actions, citizen suits, workers' compensation, common law causes of actions, CERCLA and RCRA strategies, the effect of Daubert and Frye on expert testimony, and the role of insurance, as well as cutting edge issues – biomarker evidence of injury and exposure, seller disclosure of clandestine meth labs, landlord lead paint liability, employer liability in take-home asbestos exposure – plus an expanding section on pharmatorts including SSRI suicidality claims. Features of the second edition include:

  • How to structure a toxic tort case from either the plaintiff or defendant's perspective
  • Overview of scientific principles underlying toxic torts
  • Effect of Daubert and Frye on the admissibility of expert testimony including differential diagnosis
  • Review of the "any exposure" asbestos cases
  • Thorough coverage of take-home asbestos cases, including negligence and strict liability theories
  • Overview of biomarkers and their use as evidence of exposure and injury
  • How the U.S. Court of Federal Claims has handled the vaccine cases
  • Expanding section on pharmatorts including thorough coverage of SSRI suicidality claims